Opening the Future of Medical Innovation: READYCURE
READYCURE is a pioneering company founded in 2021,
dedicated to developing AI-based digital X-ray solutions for
treating degenerative neurological diseases such as
Alzheimer’s and Parkinson’s disease.
Based on preclinical and exploratory clinical research results on
the therapeutic effects of low-dose pulse beam radiation therapy,
we are developing our exclusive treatment system, HeLaXON.

By building a therapeutic ecosystem that combines conventional
neurological drug treatments with digital X-ray therapy,
we aim to provide safer and more effective treatments for
patients suffering from degenerative neurological diseases like Alzheimer’s.

Our ultimate goal is to become a leader in the diagnosis and
treatment of neurodegenerative diseases, enhancing the quality of
life for both patients and caregivers.
Driven by a passion for a brighter future and learning
from past experiences, we are committed to creating a more
promising future through continuous innovation and
a sense of social responsibility.